Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Bernd Melchers | Director | Jan 29, 2024 | |||
Clemens Mayr | Director | Jan 29, 2024 | |||
Mark Nawacki | Director | Jan 29, 2024 | |||
ATAI Life Sciences N.V. | 10%+ Owner | Apr 19, 2024 | |||
Andre Godin | President and CFO | Jan 29, 2024 | |||
David Kideckel | SVP, Corp. Dev&SA - Subsidiary | Apr 4, 2023 | |||
Ingrid Zerbe | Corporate Secretary | Jan 29, 2023 | |||
Tommy Kenny | SVP IP Legal Affairs Subsid | Jan 29, 2024 | |||
Horst G. Zerbe | Director | Jan 29, 2024 | |||
Karen Kalayajian | VP, Finance & Admin of Subs. | Jan 29, 2024 | |||
Nadine Paiement | VP R & D of IntelGenx Corp. | Jan 29, 2024 | |||
Dana Matzen | VP Business & Corp. Dev | Jan 29, 2023 | |||
Nina Pourhassan | VP, Quality Operations of Subs | Jan 29, 2024 | |||
Dwight Gorham | Ceo | Jan 29, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|